Prevention of Coronary Artery Disease in Women

Ellen Liu1, Allison Bigeh1, Lauren Ledingham2

  • 1Division of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA.

Insights

Cardiovascular disease is a major health concern for women, who face unique risks and historical underrepresentation in research. Recent guidelines emphasize personalized risk assessment, focusing on preventative strategies for women as the population ages.

Area of Science:

  • Cardiology
  • Women's Health
  • Preventative Medicine

Background:

  • Cardiovascular disease (CVD) is the primary cause of illness and death in women globally.
  • Women have been historically underrepresented in clinical trials, impacting evidence-based cardiovascular guidelines.
  • Gender-specific risk factors contribute to coronary heart disease susceptibility in women.

Purpose of the Study:

  • To review current understanding of cardiovascular disease in women.
  • To highlight the importance of gender-specific risk factors and recent guideline updates.
  • To emphasize the need for continued focus on cardiovascular disease prevention in aging female populations.

Main Methods:

  • Literature review of recent studies and guidelines.
  • Analysis of gender-specific risk factors in cardiovascular disease.
  • Evaluation of traditional versus enhanced cardiovascular risk assessment.

Main Results:

  • Increased attention on pregnancy-associated risk factors like preeclampsia and autoimmune disorders.
  • Updated guidelines now incorporate risk-enhancing factors beyond traditional assessment tools.
  • Growing recognition of the increasing burden of CVD in aging women.

Conclusions:

  • Preventative strategies for cardiovascular disease in women require tailored approaches.
  • Incorporating gender-specific and pregnancy-associated risks is crucial for accurate assessment.
  • Continued research and focus on prevention are vital as the female population ages.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33